Mycophenolate mofetil therapy for lupus nephritis refractory to intravenous cyclophosphamide

被引：117
|
作者：
Glicklich, D [1 ]
Acharya, A [1 ]
机构：
[1] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Div Renal, Bronx, NY 10467 USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 1998年 / 32卷 / 02期
关键词：
lupus nephritis; cyclophosphamide; mycophenolate mofetil;
D O I：
10.1053/ajkd.1998.v32.pm9708620
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
intravenous (IV) cyclophosphamide has been the treatment of choice for diffuse proliferative glomerulonephritis (DPGN) in patients with systemic lupus erythematosus (SLE), However, there is little guidance in the medical literature about what to do when this therapy fails. Mycophenolate mofetil (MMF), a new immunosuppressive agent, has been used successfully in patients with solid organ transplants and rheumatoid arthritis. We report two patients with diffuse proliferative glomerulonephritis who responded favorably to MMF therapy after IV cyclophosphamide failed. (C) 1998 by the National Kidney Foundation, Inc.
引用
收藏
页码：318 / 322
页数：5
相关论文
共 50 条
  • [41] Mycophenolate mofetil in lupus nephritis
    Cross, J
    Jayne, D
    LUPUS, 2000, 9 (09) : 647 - 650
  • [42] Mycophenolate mofetil in lupus nephritis
    Alvarez, L
    Rivera, F
    Gil, CM
    del Cerro, LAJ
    Olivares, J
    NEFROLOGIA, 2002, 22 (01): : 24 - 32
  • [43] Outcomes of multitarget therapy using mycophenolate mofetil and tacrolimus for refractory or relapsing lupus nephritis
    Choi, C-B
    Won, S.
    Bae, S-C
    LUPUS, 2018, 27 (06) : 1007 - 1011
  • [44] Combination therapy of mycophenolate mofetil and tacrolimus in lupus nephritis
    Lanata, C. M.
    Mahmood, T.
    Fine, D. M.
    Petri, M.
    LUPUS, 2010, 19 (08) : 935 - 940
  • [45] Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis?
    Paredes, Ana
    PEDIATRIC NEPHROLOGY, 2007, 22 (08) : 1077 - 1082
  • [46] Mycophenolate mofetil therapy in lupus nephritis: Clinical observations
    Dooley, MA
    Cosio, FG
    Nachman, PH
    Falkenhain, ME
    Hogan, SL
    Falk, RJ
    Hebert, LA
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1999, 10 (04): : 833 - 839
  • [47] INDUCTION THERAPY WITH SHORT-TERM HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE FOLLOWED BY MYCOPHENOLATE MOFETIL IN PATIENTS WITH PROLIFERATIVE LUPUS NEPHRITIS
    Arends, S.
    Berden, J. H.
    Grootscholten, C.
    Derksen, R. H.
    Berger, S. P.
    de Sevaux, R. G.
    Voskuyl, A. E.
    Bijl, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 540 - 540
  • [48] Induction therapy with short-term high-dose intravenous cyclophosphamide followed by mycophenolate mofetil in proliferative lupus nephritis
    Arends, S.
    Berden, J. H. M.
    Grootscholten, C.
    Derksen, R. H. W. M.
    Berger, S. P.
    de Sevaux, R. G. L.
    Voskuyl, A. E.
    Bijl, M.
    NETHERLANDS JOURNAL OF MEDICINE, 2014, 72 (09): : 481 - 490
  • [49] Can mycophenolate mofetil substitute cyclophosphamide treatment of pediatric lupus nephritis?
    Ana Paredes
    Pediatric Nephrology, 2007, 22 : 1077 - 1082
  • [50] Cyclophosphamide versus mycophenolate mofetil for initial treatment of lupus nephritis Reply
    Radhakrishnan, Jai
    Cattran, Daniel
    KIDNEY INTERNATIONAL, 2013, 83 (05) : 969 - 969
12345